Reports for STERIMAX INC
Company Name
STERIMAX INC
Totals |
||
Shortage reports |
116 |
|
Actual shortage: | 16 (14%) | |
Anticipated shortage: | 3 (3%) | |
Avoided shortage: | 2 (2%) | |
Resolved: | 95 (82%) | |
Discontinuation Reports |
5 |
|
To be discontinued: | 5 (100%) | |
Discontinued: | 0 (0%) | |
Reversed: | 0 (0%) | |
Late reports |
28 (23%) |
|
Overdue reports |
3 (13%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CEFTRIAXONE SODIUM FOR INJECTION BP | 250MG | POWDER FOR SOLUTION | Resolved | 2017-12-08 | 2017-12-23 | 32244 |
CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2019-03-29 | 2019-05-14 | 80085 |
CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162207 |
CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2023-01-27 | 2023-02-14 | 182605 |
CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2019-03-29 | 2019-05-14 | 80088 |
CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-15 | 162210 |
CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2017-05-03 | 2017-05-25 | 8810 |
CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162221 |
CALCIUM CHLORIDE INJECTION BP | 100MG | SOLUTION | Resolved | 2022-06-15 | 2022-08-05 | 162674 |
CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Resolved | 2018-05-03 | 2018-07-26 | 48190 |
CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Resolved | 2019-07-19 | 2020-01-14 | 89647 |
CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Resolved | 2022-03-03 | 2022-09-10 | 155959 |
CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Actual shortage | 2024-02-01 | 2024-02-02 | 218148 |
CALCITRIOL INJECTION USP | 2MCG | SOLUTION | Resolved | 2017-04-27 | 2021-08-11 | 8288 |
BUSULFAN FOR INJECTION | 6MG | SOLUTION | Resolved | 2019-07-26 | 2019-09-06 | 89991 |
BUPIVACAINE INJECTION BP | 2.5MG | SOLUTION | Resolved | 2018-03-20 | 2018-05-26 | 43556 |
BUPIVACAINE INJECTION BP | 2.5MG | SOLUTION | Resolved | 2018-06-05 | 2018-08-09 | 51428 |
BUPIVACAINE INJECTION BP | 2.5MG | SOLUTION | Anticipated shortage | 2023-12-18 | 2024-02-16 | 213678 |
BUPIVACAINE INJECTION BP | 2.5MG | SOLUTION | Anticipated shortage | 2023-12-18 | 2024-02-16 | 213681 |
BUPIVACAINE INJECTION BP | 5MG | SOLUTION | Resolved | 2018-06-05 | 2020-07-08 | 51424 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
STREPTOMYCIN FOR INJECTION USP | 1G | POWDER FOR SOLUTION | To be discontinued | 2023-11-06 | 2023-11-06 | 209235 |
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223140 |
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223145 |
MYCOPHENOLATE MOFETIL FOR INJECTION USP | 500MG | POWDER FOR SOLUTION | To be discontinued | 2024-01-22 | 2024-02-06 | 216963 |
BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | To be discontinued | 2024-01-15 | 2024-01-15 | 216017 |
Showing 1 to 5 of 5